Newton Biocapital has launched a new life sciences fund with initial capital commitments of €50m and a target size of €150m.
European investment firm LSP has closed its European life sciences fund LSP at €1 bn. Additionally, a €10bn fund of funds was greenlighted at the EU Council in Paris.
AiCuris will pay up to €100m to Dutch Hybridize Therapeutics BV for the development of antisense RNA therapeutics that stop BK viraemia in renal transplant patients.
AGC Biologics supports BioNTech’s manufacturing of an Omicron-based vaccine with plasmids for in vitro transcription.
EU Members States agreed on Tuesday to launch the pan-European Scale-up Initiative, which is aimed to provide €10bn for late-state tech companies.
Dutch insect protein specialist Protix has raised €50m for expansion and development from international investors and the ECBF.
Ribbon Biolabs has cashed in €18m in Series A financing led by Hadean Ventures
German mRNA and LNP specialist Ethris GmbH has closed a $26m Series B round led by Laureus Capital.
Evotec SE will use its PanOmics platform to validate and screen targets and drug candidates in ophtalmology for Boehringer Ingelheim.
Pfizer Inc and BioNTech SE have started clinical safety testing of an Omikron-specific vaccine in healthy adults 18 through 55 years of age.